Concepedia

c-Myc overexpression and endocrine resistance in breast cancer

Catriona M. McNeil, C. Marcelo Sergio, Luke R. Anderson, Claire K. Inman, Sarah A. Eggleton, Niamh Murphy, Ewan K.A. Millar, Paul Crea, James G. Kench, M. Chehani Alles,

The Journal of Steroid Biochemistry and Molecular Biology · 2006 · 88 citations · 27 references

DOI

Concepts

References

27

Tamoxifen for early breast cancer: an overview of the randomised trials

The Lancet · 1998 · 4.1K citations

, , +9

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer

Anthony Howell, Jack Cuzick, M Baum et al. · The Lancet · 2005 · 2.3K citations

, , +6

Myc represses the p21 <sup>(WAF1/CIP1)</sup> promoter and interacts with Sp1/Sp3

Andrei L. Gartel, Xin Ye, Eugene Goufman et al. · Proceedings of the National Academy of Sciences · 2001 · 427 citations · Full text

, , +17

Prognostic Relevance of Gene Amplifications and Coamplifications in Breast Cancer

Khawla S. Al‐Kuraya, Peter Schraml, J. Torhorst et al. · Cancer Research · 2004 · 349 citations

, , +15

Stimulation of c-myc oncogene expression associated with estrogen-induced proliferation of human breast cancer cells.

D. Dubik, Thomas C. Dembinski, Robert P. C. Shiu · PubMed · 1987 · 279 citations

, , +15